The Weil Institute & Abiomed: Teaming Up to Restart the Heart

The Weil Institute Pre-Clinical Critical Care Laboratory (PC3L) is collaborating with medical device maker Abiomed, Inc. to examine the potential of using Abiomed Impella CP® left ventricular assist device as a resuscitative strategy for sudden cardiac arrest.

Critical Care Life Sup..., Cardiovascular Care, Animal Lab, Critical Care LabKate MurphyJanuary 31, 2022Critical Care Life Support, Critical Care Lab, Pre-Clinical Operative and Intensive Care Unit, Featured Research Project

UM Innovation Partnerships Highlights MCIRCC in Feature Story

In the seven years since its founding, MCIRCC has collaborated with the Office of Technology transfer to spin out eight companies and licensed 14 products that are making positive impacts on patients in the critical care setting.

Critical Care Lab, Commercialization Coac..., Clinical Research Unit, Cardiovascular Care, Critical Care Life Sup..., Neurological Care, Data Science Services, Proposal Development UnitMegan VanStrattAugust 18, 2021MCIRCC

Important Information for Researchers regarding International Collaborations

Amid growing federal concerns regarding "foreign influence" on research activity, some federal agencies have issued statements emphasizing the need for increased transparency with respect to international collaborations. Failure to comply could jeopardize the ability of faculty and the university to receive federal support for research.

Cardiovascular Care, Critical Care Life Sup..., Neurological Care, Sepsis, Trauma, Trauma & Combat Ca...mukatelyJuly 24, 2019NIH, NSF, U-M Research

‘M-RISE’ Research Program Aims to Prevent Brain Damage Caused by Cardiac Arrest

American Heart Association funding will allow Michigan Medicine to establish a leading research and training program, housed at MCIRCC, with a focus on preventing brain damage caused by out-of-hospital cardiac arrest.

Cardiovascular Care, Critical Care Life Sup..., EC3, Proposal Development UnitmukatelyJune 24, 2019

Predictive analytic technology developed at MCIRCC gets $11.5 million investment

Michigan Medicine spinoff company receives the funding to commercialize the technology as its first product.

Critical Care Life Sup..., Data Science Services, Sepsis, Trauma, Trauma & Combat Ca...mukatelyApril 3, 2019AHI, Analytic for Hemodynamic Instability, Data Science, Fifth Eye Inc-

HIT Consultant: UM Spinout Fifth Eye Lands $11.5M for Early Warning Patient Deterioration System for Hospitals

Fifth Eye Inc. has raised $11.5 million in Series A funding led by Arboretum Ventures and Cultivation Capital. Other participants in the round included MINTS, the direct investing arm of the University of Michigan’s endowment, along with additional capital from previous investors Invest Michigan and 35 private angel investors.

Fifth Eye Press Release: https://fiftheye.com/wp-content/uploads/2019/03/fifth-eye-press-release-final.pdf